News
Last couple of days to register. All attendees receive a 60 day free trial of all Cresset desktop solutions. twitter.com/cressetgroup/s…
The importance of understanding protein-protein and protein-ligand interactions in immuno-oncology Immuno-oncology represents a new paradigm in the fight against cancer and ...
Historical context and significance Despite cancer being a disease that has been with us for centuries, it has never been ...
Therapeutic protein degradation by design; Presentations from recent meetings; Review of Efficient Drug Discovery Through Connected Chemistry symposium; New website
Thank you to all attendees who contributed to the success of the Cresset User Group Meeting 2019. As I'm sure ...
Merck Research Laboratories, Boston, was the host for this meeting with a central theme 'Design, Make, Test and Analysis', effecting ...
The old problem and the new paradigm Classical small molecule drug paradigms generally involve intervention at a ligand protein binding ...
Cambridge, UK – 12th June 2019 – Cresset, innovative provider of computational solutions for small molecule drug discovery and design ...
Cambridge, UK – 4 June 2019 – Cresset, innovative provider of outstanding software for molecule discovery and design, announces the ...
Release of PickR™ V1.0 enables selection of electrostatically diverse monomers for high quality libraries and better intellectual property Unlike existing ...
Unlike existing methods, PickR™ V1.0 uses the 3D electrostatic and shape properties of molecules to cluster and select R-groups for inclusion ...
I am delighted to announce that a new release of Cresset workflow components for the Pipeline Pilot™ environment is now available. These ...
Kinase inhibitors have established themselves as cancer therapeutics but does this family of enzymes have a role to play in ...